AJU IB Investment

Active

Website LinkedIn

Updated: Apr 1, 2026 ·

Financial History

Total Raised

N/A

Valuation

N/A

Investments Made

Date	Company	Round	Lead Investor(s)	Co-Investor(s)
Jul 14, 2025	Illimis Therapeutics	$41.8M Series B	Yohan Kim	A Ventures, Company K Partners, Daily Partners, GS Ventures, Hana Ventures, IMM Investment, Industrial Bank of Korea, Korea Development Bank, LB Investment, Maple Investment Partners, QUAD Investment Management, Schmidt, Shinhan Venture Investment, S&S Investment, TS Investment, Jiwoong Chun
Nov 7, 2023	MEZOO	$14.0M Series B	—	Dong-A ST, E&Venture Partners, Industrial Bank of Korea, Korea Technology Finance Corporation, Shinhan Venture Investment, SJ Investment Partners, Timefolio Asset Management, Woori Venture Partners
Nov 21, 2022	Laundrygo	$36.8M Series C	H&Q Korea	Altos Ventures, Badgers Investment, Hanwha Investment, KB Securities, Musinsa, Pebbles Investment, SoftBank Ventures Asia
Nov 1, 2021	Trefoil Therapeutics	$28.0M Series A	Access Biotechnology, Stella Robertson	5AM Ventures, Canaan Partners, Hatteras Venture Partners, Correlation Ventures, ExSight Ventures, InFocus Capital Partners
Aug 9, 2021	S-Alpha Therapeutics	$8.7M Alpha Therapeutics - Series A	STIC Ventures	Future Play, Hana Ventures, Korea Investment Partners, SJ Investment Partners, Stonebridge Ventures, Timewise Investment, Tony Investment
Dec 16, 2020	S-Alpha Therapeutics	$2.7M Alpha Therapeutics - Seed	—	Hana Ventures, SJ Investment Partners, STIC Ventures, Tony Investment
Dec 12, 2019	SparkPlus	$25.2M Series B	—	Aju Hotels and Resorts, Asia Cement, InterVest, Koramco, STIC Ventures
Nov 1, 2019	FamePick	$5.0M Series A	InterVest	Felicis Ventures, Kima Ventures, David Marcus, Steve Anavi, JB Lee, John Kim, Kai Huang, Woo Park, Detroit Venture Partners, Mirae Asset Venture Investment
Oct 16, 2019	Leferi	$8.0M Series B	—	GS Shop, NH Investment & Securities, Shinhan Securities
Oct 3, 2019	Arcellx	$85.0M Series B	Hugo Beekman, Lewis (Rusty) Williams	JVC Investment Partners, LG Technology Ventures, Mirae Asset Capital, Mirae Asset Venture Investment, NEA, Novo Holdings, SR One, Takeda Ventures
Sep 24, 2019	Amphivena Therapeutics	$62.0M Series C	NanoDimension, Qiming Venture Partners USA	Franklin Berger, Industrial Investors, Kaitai Capital, Korys Merieux, MPM Capital, Nawton Limited, Tekla Capital Management
Aug 24, 2019	Tibit Communications	$25.0M Series B	Dave Flanagan	Michael Jeon, Par Lange
Mar 26, 2019	Triple	$26.5M Series B	—	AJ Capital Partners, Brookfield Asset Management, DSC Investment, IBK Capital, KB Investment, Kiwoom Investment, Korea Investment Partners, Jang Seong-yeop, Mirae Asset Venture Investment, Neoflux, Smilegate Investment
Nov 1, 2018	Kymera Therapeutics	$65.0M Series B	Bessemer Venture Partners, Li Wei	Creacion Ventures, MPM Capital, Red Tree Venture Capital, Hatteras Venture Partners, MRL Ventures Fund, Sanofi Ventures
Jul 25, 2017	Kezar Life Sciences	$50.0M Series B	Bihua Chen, Morningside	Bay City Capital, Cowen Healthcare Investments, EcoR1 Capital, Omega Funds, Pappas Ventures, Qiming Venture Partners
May 1, 2016	G1 Therapeutics	$47.0M Series C	Bihua Chen	Catalio Capital, Hatteras Venture Partners, RA Capital, Ryan Allis, Cowen Private Investments, Eshelman Ventures, Franklin Templeton, Lumira Ventures, MedImmune Ventures, Mountain Group Partners, RA Capital Management, Rock Springs Capital, Tavistock Group
Dec 3, 2015	Clearside Biomedical	$20.0M Series C	—	Cormorant Asset Management, Perceptive Advisors, Rock Springs Capital
Sep 1, 2015	Selecta Biosciences	$38.0M Series E	OrbiMed	5AM Ventures, Advent Life Sciences, ARCH Venture Partners, Atlas Venture, Flagship Ventures, NanoDimension, Polaris Partners, The Column Group, Flagship Ventures, Leukon Investments, NanoDimension, Osage University Partners, Polaris Partners, Ridgeback Capital Investments, Rusnano, Sanofi Ventures, Sphera Healthcare
Jun 16, 2015	Kezar Life Sciences	$23.0M Series A	—	9W Capital Management, Cormorant Asset Management, EcoR1 Capital, Morningside, Omega Funds, Onyx Pharmaceuticals
Dec 2, 2014	Apellis Pharmaceuticals	$33.0M Series C	AJU IB Investment, Epidarex Capital, Gerald Chan	—
Oct 1, 2014	Aileron Therapeutics	$33.0M Series E	AJU IB Investment	Abingworth, ATP (Apple Tree Partners), Apple Tree Partners, Excel Venture Management, Lilly Ventures, Novartis, Roche, SR One
Sep 15, 2014	Molecular Templates	$3.5M Series C Extension	Timothy Sullivan	—
Aug 27, 2014	Bellicum Pharmaceuticals	$55.0M Series C	—	AVG Ventures, Jennison Associates, Joseph Edelman, RA Capital Management, Redmile Group, Remeditex Ventures, Ridgeback Capital Investments, Sabby Capital

Financial History

Total Raised

N/A

Valuation

N/A

Leadership Team

Key people at AJU IB Investment.

Leadership Team

Key people at AJU IB Investment.

Jeong Moo-il

Team manager